1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Bioengineering Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Bioengineering Market Revenue and Volume Forecast, by Product/Sub-Sector
8.1.1. Biomedical Engineering
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Genetic Engineering
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Biotechnology
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Tissue & Regenerative Engineering
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Biomechanics Engineering
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Biomaterials
8.1.6.1. Market Revenue and Volume Forecast
8.1.7. Nano-Biotechnology
8.1.7.1. Market Revenue and Volume Forecast
8.1.8. Bioinformatics
8.1.8.1. Market Revenue and Volume Forecast
8.1.9. Biochemical Engineering
8.1.9.1. Market Revenue and Volume Forecast
8.1.10. Synthetic Biology & Bioprocessing
8.1.10.1. Market Revenue and Volume Forecast
9.1. Bioengineering Market Revenue and Volume Forecast, by Technology
9.1.1. Nanobiotechnology
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Tissue Engineering & Regenerative Technologies
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. DNA & Genome Sequencing
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Cell-Based Assay Technologies
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Fermentation & Bioprocessing Technologies
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Gene Editing Technologies
9.1.6.1. Market Revenue and Volume Forecast
9.1.7. Computational / AI-Driven Bioengineering Platforms
9.1.7.1. Market Revenue and Volume Forecast
10.1. Bioengineering Market Revenue and Volume Forecast, by Application
10.1.1. Healthcare & Medical Devices
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Pharmaceuticals & Biotherapeutics
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Agriculture & Crop Engineering
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Food & Nutritional Biotechnology
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Environmental & Bioremediation Applications
10.1.5.1. Market Revenue and Volume Forecast
10.1.6. Industrial Biotechnology & Bio-Manufacturing
10.1.6.1. Market Revenue and Volume Forecast
10.1.7. Research & Academic Applications
10.1.7.1. Market Revenue and Volume Forecast
11.1. Bioengineering Market Revenue and Volume Forecast, by End-User
11.1.1. Pharmaceutical & Biotechnology Companies
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Hospitals & Clinical Centers
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Agricultural & Food Processing Companies
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Research Institutes & Academic Laboratories
11.1.4.1. Market Revenue and Volume Forecast
11.1.5. Government & Public Health Organizations
11.1.5.1. Market Revenue and Volume Forecast
11.1.6. Industrial Biotechnology Firms
11.1.6.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.1.2. Market Revenue and Volume Forecast, by Technology
12.1.3. Market Revenue and Volume Forecast, by Application
12.1.4. Market Revenue and Volume Forecast, by End-User
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.1.5.2. Market Revenue and Volume Forecast, by Technology
12.1.5.3. Market Revenue and Volume Forecast, by Application
12.1.5.4. Market Revenue and Volume Forecast, by End-User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.1.6.2. Market Revenue and Volume Forecast, by Technology
12.1.6.3. Market Revenue and Volume Forecast, by Application
12.1.6.4. Market Revenue and Volume Forecast, by End-User
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.2.2. Market Revenue and Volume Forecast, by Technology
12.2.3. Market Revenue and Volume Forecast, by Application
12.2.4. Market Revenue and Volume Forecast, by End-User
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.2.5.2. Market Revenue and Volume Forecast, by Technology
12.2.5.3. Market Revenue and Volume Forecast, by Application
12.2.5.4. Market Revenue and Volume Forecast, by End-User
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.2.6.2. Market Revenue and Volume Forecast, by Technology
12.2.6.3. Market Revenue and Volume Forecast, by Application
12.2.6.4. Market Revenue and Volume Forecast, by End-User
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.2.7.2. Market Revenue and Volume Forecast, by Technology
12.2.7.3. Market Revenue and Volume Forecast, by Application
12.2.7.4. Market Revenue and Volume Forecast, by End-User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.2.8.2. Market Revenue and Volume Forecast, by Technology
12.2.8.3. Market Revenue and Volume Forecast, by Application
12.2.8.4. Market Revenue and Volume Forecast, by End-User
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.3.2. Market Revenue and Volume Forecast, by Technology
12.3.3. Market Revenue and Volume Forecast, by Application
12.3.4. Market Revenue and Volume Forecast, by End-User
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.3.5.2. Market Revenue and Volume Forecast, by Technology
12.3.5.3. Market Revenue and Volume Forecast, by Application
12.3.5.4. Market Revenue and Volume Forecast, by End-User
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.3.6.2. Market Revenue and Volume Forecast, by Technology
12.3.6.3. Market Revenue and Volume Forecast, by Application
12.3.6.4. Market Revenue and Volume Forecast, by End-User
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.3.7.2. Market Revenue and Volume Forecast, by Technology
12.3.7.3. Market Revenue and Volume Forecast, by Application
12.3.7.4. Market Revenue and Volume Forecast, by End-User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.3.8.2. Market Revenue and Volume Forecast, by Technology
12.3.8.3. Market Revenue and Volume Forecast, by Application
12.3.8.4. Market Revenue and Volume Forecast, by End-User
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.4.2. Market Revenue and Volume Forecast, by Technology
12.4.3. Market Revenue and Volume Forecast, by Application
12.4.4. Market Revenue and Volume Forecast, by End-User
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.4.5.2. Market Revenue and Volume Forecast, by Technology
12.4.5.3. Market Revenue and Volume Forecast, by Application
12.4.5.4. Market Revenue and Volume Forecast, by End-User
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.4.6.2. Market Revenue and Volume Forecast, by Technology
12.4.6.3. Market Revenue and Volume Forecast, by Application
12.4.6.4. Market Revenue and Volume Forecast, by End-User
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.4.7.2. Market Revenue and Volume Forecast, by Technology
12.4.7.3. Market Revenue and Volume Forecast, by Application
12.4.7.4. Market Revenue and Volume Forecast, by End-User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.4.8.2. Market Revenue and Volume Forecast, by Technology
12.4.8.3. Market Revenue and Volume Forecast, by Application
12.4.8.4. Market Revenue and Volume Forecast, by End-User
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.5.2. Market Revenue and Volume Forecast, by Technology
12.5.3. Market Revenue and Volume Forecast, by Application
12.5.4. Market Revenue and Volume Forecast, by End-User
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.5.5.2. Market Revenue and Volume Forecast, by Technology
12.5.5.3. Market Revenue and Volume Forecast, by Application
12.5.5.4. Market Revenue and Volume Forecast, by End-User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product/Sub-Sector
12.5.6.2. Market Revenue and Volume Forecast, by Technology
12.5.6.3. Market Revenue and Volume Forecast, by Application
12.5.6.4. Market Revenue and Volume Forecast, by End-User
13.1. Thermo Fisher Scientific Inc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Roche Holding AG, Pfizer Inc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Illumina, Inc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Agilent Technologies, Inc
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. AstraZeneca plc
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Lonza Group Ltd
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Johnson & Johnson
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Abbott Laboratories
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Moderna Inc
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Abbott
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client